Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 1284

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 5
Chunk 1284
---
 outstanding (excluding 3,467,954 shares subject to possible redemption) at December 31, 2023

    216

    216

    Additional paid-in capital

    -

    -

    Accumulated deficit

    (8,333,627
    )

    (3,907,008
    )
  
    Total Stockholders’ Deficit

    (8,333,411
    )

    (3,906,792
    )
  
    Total Liabilities and Stockholders’ Deficit
     
    $
    2,303,041

    $
    36,627,733

The accompanying notes are an integral part
of the consolidated financial statements.

F-3

OSR HOLDINGS, INC.

(f/k/a Bellevue Life
Sciences Acquisition Corp.)

CONSOLIDATED
STATEMENTS OF OPERATIONS

    For the Years Ended

    December 31,

    2024

    2023

    EXPENSES

    General and administrative expenses
     
    $
    3,524,549

    $
    1,830,700

    Loss from operations

    (3,524,549
    )

    (1,830,700
    )

    Other income (expense):

    Interest earned on investments held in the Trust Account

    1,450,228

    2,775,291

    Interest income

    2,181

    -

    Interest expense

    (43,011
    )

    -

    Total other income, net

    1,409,398

    2,775,291

    Income (loss) before provision for income taxes

    (2,115,151
    )

    944,591

    Provision for income taxes

    (295,728
    )

    (540,811
    )
  
    NET INCOME (LOSS)
     
    $
    (2,410,879
    )
     
    $
    403,780

    WEIGHTED AVERAGE SHARES OUTSTANDING

    Basic

    4,481,692

    7,688,260

    Diluted

    4,481,692

    7,719,699

    BASIC AND DILUTED NET INCOME (LOSS) PER SHARE

    Basic
     
    $
    (0.54
    )
     
    $
    0.05

    Diluted